PRRT2 and chronic kidney disease: Future studies should now address the putative therapeutic potential of specific modulation of specific osteoblast’s Gαq/11-protein signaling in mice with CKD and low and high phosphate diet, e.g., by novel PTH analog selectively activating PKC [24].